TY - JOUR T1 - GWAS meta-analysis reveals dual neuronal and immunological etiology for pain susceptibility JF - medRxiv DO - 10.1101/2021.08.23.21262510 SP - 2021.08.23.21262510 AU - Evelina Mocci AU - Kathryn Ward AU - Susan G. Dorsey AU - Seth A. Ament Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/08/26/2021.08.23.21262510.abstract N2 - Chronic pain is at epidemic proportions in the United States, represents a significant burden on our public health system and is coincident with a growing opioid crisis. While numerous genetic risk factors have been identified, its genetic basis remains poorly understood. Here, we conducted a meta-analysis of genome-wide association study (GWAS) summary statistics from seventeen pain susceptibility traits in the UK Biobank. This analysis revealed 99 genome-wide significant risk loci, of which 62 have not been previously associated with a pain-related trait. Risk loci were enriched for genes involved in neurological and inflammatory pathways. Two-sample Mendelian randomization indicated that depression, neuroticism, and immunological traits mediate many of these effects. These analyses double the number of known risk loci for pain susceptibility and support dual causation from neuronal and immunological genes, providing leads toward targets for novel pain medications.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a grant from the National Institute of Nursing Research to S.G.D. (P30 NR016579).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This meta-analysis started from GWAS summary statistics and did not utilize any individual-level data from the underlying cohorts.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesComplete GWAS summary statistics will be made available through the GWAS Catalog (https://www.ebi.ac.uk/gwas/). All other data and results are contained in the manuscript and supplementary files. ER -